39 results
8-K
EX-99.1
PCRX
Pacira BioSciences Inc
7 May 24
Pacira BioSciences Reports First Quarter 2024 Financial Results
4:01pm
of excluding both discrete tax expenses associated with non-deductible stock-based compensation and tax expenses related to executive compensation … executive compensation.
(6) For the three months ended March 31, 2024, there were no non-GAAP adjustments when calculating the diluted weighted average
8-K
EX-99.1
PCRX
Pacira BioSciences Inc
29 Feb 24
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
8:03am
income tax rate excludes costs related to discrete non-deductible executive compensation, offset by excluding benefits from discrete tax credits
8-K
EX-99.1
yp71sdeyb023
2 Nov 23
Pacira BioSciences Reports Third Quarter 2023 Financial Results
8:01am
CORRESP
0h4rewhy6yc
6 Oct 23
Correspondence with SEC
12:00am